News

Pharmabiz20h
Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol use disorder
Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol use disorder: Vancouver, Canada Saturday, July 5, 2025, 18:0 ...
Pharmabiz21h
Dyadic International announces strategic rebrand to Dyadic Applied BioSolutions
Dyadic International announces strategic rebrand to Dyadic Applied BioSolutions: Jupiter, Florida Saturday, July 5, 2025, 17:00 Hrs [IST] Dyadic International, Inc, a global biote ...
Pharmabiz22h
Thermo Fisher Scientific’s NGS assay, Oncomine Dx Express Test receives US FDA approval as a companion diagnostic for Dizal’s Zegfrovy
Carlsbad, California Saturday, July 5, 2025, 16:00 Hrs [IST] ...
Pharmabiz23h
Theratechnologies signs binding arrangement agreement with CB Biotechnology to buy all issued and outstanding common shares of the company
Theratechnologies signs binding arrangement agreement with CB Biotechnology to buy all issued and outstanding common shares of the company: Montreal Saturday, July 5, 2025, 15:00 ...